Skin Cancer Treatment in India

Access India's expert dermatologic and surgical oncologists for complete skin cancer care — from Mohs micrographic surgery and wide local excision to advanced immunotherapy and targeted BRAF/MEK therapy for melanoma — at 70–80% lower cost than the USA or UK.

Overview of Skin Cancer

Skin cancer is the abnormal, uncontrolled growth of skin cells. It is the most common type of cancer worldwide, with over 1.5 million new cases diagnosed annually. While most skin cancers are highly curable when detected early, advanced melanoma — the most aggressive form — can be life-threatening if left untreated.

India has emerged as a top destination for skin cancer treatment due to its world-class dermatologic oncology centres, affordable pricing, and access to the latest immunotherapies and targeted drugs approved globally. Hospitals in Delhi, Mumbai, Chennai, and Bangalore are equipped with advanced dermatoscopy, confocal microscopy, and Mohs micrographic surgery capabilities that match Western standards.

For international patients from Africa and the Middle East, India offers a unique advantage: experienced oncologists who treat the full spectrum of skin cancers — from common basal cell carcinoma (BCC) to rare Merkel cell carcinoma — using multidisciplinary tumour boards that personalise treatment for each patient.

Types of Skin Cancer

Signs & Symptoms of Skin Cancer

• A — Asymmetry: One half of the mole does not match the other half
• B — Border: Irregular, ragged, or blurred edges
• C — Colour: Uneven colour with shades of brown, black, tan, red, white, or blue
• D — Diameter: Larger than 6mm (about the size of a pencil eraser)
• E — Evolving: The mole is changing in size, shape, or colour over time
• Non-healing sore: A sore that does not heal within 3–4 weeks
• New growth: A new spot or bump that grows larger over weeks or months
• Pearly or waxy bump: Common in BCC, especially on sun-exposed areas like the face and neck
• Red, scaly patch: A firm, red nodule or flat lesion with a scaly, crusted surface (SCC)
• Itching or bleeding: A mole or lesion that bleeds, itches, or becomes painful

Causes & Risk Factors

Staging

• Stage 0 (Melanoma in Situ): Cancer is only in the epidermis (top layer of skin). Curable with simple excision. 5-year survival rate: 99%.
• Stage I: Tumour is ≤2mm thick, may or may not be ulcerated. No lymph node spread. Treated with wide local excision. 5-year survival: 92–97%.
• Stage II: Tumour is >2mm thick or deeply ulcerated. No lymph node spread. Wide excision with sentinel lymph node biopsy recommended. 5-year survival: 53–81%.
• Stage III: Cancer has spread to regional lymph nodes or developed satellite/in-transit metastases. Requires surgery + adjuvant immunotherapy or targeted therapy. 5-year survival: 40–78%.
• Stage IV (Metastatic): Cancer has spread to distant organs (lungs, liver, brain, bone). Treated with systemic immunotherapy (Pembrolizumab, Nivolumab) and targeted therapy (BRAF/MEK inhibitors). 5-year survival: 15–20% but improving rapidly with modern drugs.

Diagnosis

• Dermoscopy: A non-invasive technique using a handheld microscope to examine skin lesions in detail, improving diagnostic accuracy for melanoma.
• Skin Biopsy: The gold standard. Types include punch biopsy, shave biopsy, excisional biopsy, and incisional biopsy. Tissue is examined by expert dermatopathologists.
• Sentinel Lymph Node Biopsy (SLNB): Determines if melanoma has spread to nearby lymph nodes. Critical for staging and treatment planning.
• PET-CT Scan: Used for advanced melanoma to detect metastases in distant organs such as the lungs, liver, or brain.
• Genetic/Molecular Testing: BRAF V600E/K mutation testing, NRAS, and c-KIT testing guide targeted therapy decisions for advanced melanoma.
• Confocal Microscopy: Available at select Indian centres, this provides near-histological resolution images of the skin non-invasively.

Treatment Options Available in India

1. Surgical Interventions

Mohs Micrographic Surgery is the gold standard for BCC and SCC, especially on the face. It removes cancer layer by layer, examining each under a microscope, achieving the highest cure rate (99% for primary BCC) while preserving maximum healthy tissue. Wide Local Excision is standard for melanoma, removing the tumour with adequate margins (0.5cm to 2cm depending on thickness). Lymph Node Dissection involves complete lymph node removal if sentinel node is positive.

2. Immunotherapy

Revolutionary treatment for advanced melanoma. Checkpoint inhibitors like Pembrolizumab (Keytruda) and Nivolumab (Opdivo) have transformed outcomes for Stage III and IV melanoma. Combination therapy with Ipilimumab + Nivolumab achieves response rates of 50–60%. These drugs are available in India at significantly lower cost than in the US/UK.

3. Targeted Therapy

For BRAF-mutant melanoma (~50% of melanomas), BRAF inhibitors (Vemurafenib, Dabrafenib) combined with MEK inhibitors (Trametinib, Cobimetinib) offer rapid tumour shrinkage. Response rates exceed 65%. India provides these FDA-approved drugs through established pharmaceutical supply chains.

4. Radiation Therapy

Used as adjuvant therapy after surgery, or as primary treatment for patients who cannot undergo surgery. Advanced techniques include IMRT, IGRT, and Proton Therapy for precise tumour targeting with minimal damage to surrounding tissue.

5. Chemotherapy

Less commonly used for skin cancer but may be employed for advanced SCC or Merkel cell carcinoma. Regimens include Dacarbazine, Temozolomide, and Carboplatin/Paclitaxel combinations.

Why Treat Skin Cancer in India?

India offers world-class cancer care at a fraction of Western costs, with no compromise on quality or outcomes.

Treatment / Procedure	Cost in US/UK	Cost in India
Mohs Micrographic Surgery	$3,000 – $5,000	$800 – $1,500
Wide Local Excision (Melanoma)	$5,000 – $15,000	$1,500 – $3,500
Immunotherapy — Pembrolizumab (per cycle)	$10,000 – $15,000	$1,800 – $3,000
Targeted Therapy — BRAF+MEK (per month)	$12,000 – $18,000	$2,000 – $4,000
Radiation Therapy (full course)	$10,000 – $20,000	$3,000 – $5,000

Top Cities & Hospitals

Cities like Delhi, Mumbai, Chennai, and Bangalore host JCI and NABH accredited facilities such as Apollo Hospitals, Fortis Healthcare, Medanta, Kokilaben Dhirubhai Ambani Hospital, and Tata Memorial Centre. These institutions have dedicated dermatologic oncology units with Mohs-trained surgeons and access to the full range of immunotherapy drugs.

Specialist Oncologists

Indian oncologists are globally trained, many holding fellowships from the US, UK, and Europe. They bring decades of experience in handling complex and advanced-stage skin cancers, ensuring high success rates and compassionate care for international patients. Notable specialists include Dr. Mandar Nadkarni (Kokilaben Hospital, Mumbai), Dr. Archit Pandit (Fortis Hospital), and Dr. Ashok Kumar Vaid, Padma Shri awardee and Chairman of Medical Oncology at Medanta.

Key Facts

• BRAF V600E mutation testing available within 5 days at major Indian centres
• Immunotherapy for melanoma costs $1,800–$3,000 per cycle in India vs $10,000–$15,000 in USA
• Mohs surgery available in major Indian metro cities with 99% cure rates for primary BCC
• Dermoscopy and confocal microscopy for non-invasive diagnosis available
• Acral melanoma (affects palms, soles, under nails) — more common in darker-skinned patients — is well-treated in India

Frequently Asked Questions

Related Cancer Types